OVARIAN CARCINOSARCOMA
Clinical trials for OVARIAN CARCINOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN CARCINOSARCOMA trials appear
Sign up with your email to follow new studies for OVARIAN CARCINOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for devastating Women's cancers: experimental combo therapy enters major trial
Disease control Recruiting nowThis international study is testing whether combining two newer drugs (dostarlimab and niraparib) works better than using niraparib alone or standard chemotherapy for women with rare, aggressive uterine or ovarian carcinosarcoma that has returned after initial treatment. The tria…
Matched conditions: OVARIAN CARCINOSARCOMA
Phase: PHASE2, PHASE3 • Sponsor: ARCAGY/ GINECO GROUP • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New pill targets advanced cancers in first human trial
Disease control Recruiting nowThis is an early-stage study to test a new oral medication called VLS-1488 in adults with advanced solid tumors. The main goals are to find a safe dose and see if the drug shows any early signs of helping to control the cancer. The study is for people with specific advanced cance…
Matched conditions: OVARIAN CARCINOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Volastra Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC